BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 654990)

  • 41. [Is it possible to improve erythrocyte deformability in vascular diseases in the aged? Preliminary study].
    Crolle G; Cucca S; Gosparini B; Baso G; Martechini A; Urbani N; Vattolo S
    Minerva Med; 1985 Jul; 76(28-29):1349-51. PubMed ID: 3895045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CDP-choline as a biological supplement during neurorecovery: a focused review.
    Arenth PM; Russell KC; Ricker JH; Zafonte RD
    PM R; 2011 Jun; 3(6 Suppl 1):S123-31. PubMed ID: 21703569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Involuntary movement due to vascular lesion in the basal ganglia].
    Ohye C
    No To Shinkei; 1993 Feb; 45(2):119-27. PubMed ID: 8476661
    [No Abstract]   [Full Text] [Related]  

  • 44. [Position of cyticholine in pneumologic therapy].
    Cornia G; Gramiccioni E
    Minerva Med; 1975 Nov; 66(77):4053-5. PubMed ID: 1041758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A; Sanjurjo P; Vázquez Cordero C
    An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapeutic effects of CDP-choline and premarin in acute experimental pancreatitis].
    Yamada N; Nakamura K; Zeze F; Ishii K
    Nihon Rinsho; 1976 Aug; 34(8):1758-61. PubMed ID: 185437
    [No Abstract]   [Full Text] [Related]  

  • 47. Influence of CDP-choline administration on the aortic wall lesions in dietically hypercholesterolaemic rabbits: a morphometric evaluation.
    Weber G; Auteri A; Bianciardi G; Fabrini P; Resi L; Salvi M; Toti P; Tanganelli P
    Drugs Exp Clin Res; 1989; 15(6-7):321-3. PubMed ID: 2591303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [CDP-choline improves the postoperative rehabilitation of patients with cerebral risk].
    Bricourt MO; Ghnassia MD; Legout-Montdargent V
    Agressologie; 1990; 31(7):457-63. PubMed ID: 2088110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrathecal administration of CDP-choline into the lower lumbar subarachnoid space in two patients with post-traumatic akinetic mutism.
    Tanji H; Takahashi M; Masu K; Kawaguchi Y; Abe H
    Fukushima J Med Sci; 1976 Mar; 22(1-2):31-47. PubMed ID: 1037478
    [No Abstract]   [Full Text] [Related]  

  • 50. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke.
    Hurtado O; Cárdenas A; Pradillo JM; Morales JR; Ortego F; Sobrino T; Castillo J; Moro MA; Lizasoain I
    Neurobiol Dis; 2007 Apr; 26(1):105-11. PubMed ID: 17234423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease.
    Cubells JM; Hernando C
    Clin Ther; 1988; 10(6):664-71. PubMed ID: 3064905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CDP-choline: acute toxicity study.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
    Tazaki Y; Sakai F; Otomo E; Kutsuzawa T; Kameyama M; Omae T; Fujishima M; Sakuma A
    Stroke; 1988 Feb; 19(2):211-6. PubMed ID: 3278412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrathecal pharmacotherapy in coma.
    Ogashiwa M; Takeuchi K
    Acta Neurochir (Wien); 1976; 34(1-4):37-44. PubMed ID: 989256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of cytidine-diphosphate choline (CDP-choline) on brain lipid changes during aging.
    De Medio GE; Trovarelli G; Piccinin GL; Porcellati G
    J Neurosci Res; 1984; 11(1):49-58. PubMed ID: 6708133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of CDP-choline on the recovery of patients with head injury.
    Calatayud Maldonado V; Calatayud Pérez JB; Aso Escario J
    J Neurol Sci; 1991 Jul; 103 Suppl():S15-8. PubMed ID: 1940960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection from ischemia-reperfusion damage in patients with stroke: the role of rutin and GSH.
    Ortolani O; Caggiano M; Mannelli R; Gogliettino A; Tufano R
    Transplant Proc; 1995 Oct; 27(5):2877-8. PubMed ID: 7482952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.